Reverse Stock Split
| Reverse Stock Split : |
| |
|
Untitled Document
|
| |
FDA Approves Drug for Patients with Advanced Prostate CancerDecember 29, 2008 -- The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer.
Novartis strengthens vaccine pipeline with agreement for novel CMV vaccines candidateBasel, December 29, 2008 - Novartis has strengthened its vaccines pipeline through an exclusive agreement to license AlphaVax' investigational Cytomegalovirus (CMV) vaccine program. This CMV...
Actavis Totowa and FDA Reach Agreement on Consent DecreeDecember 29, 2008--Actavis Inc. today announced that it has reached agreement on a Consent Decree of Permanent Injunction with the Food and Drug Administration (FDA) regarding the company's Actavis...
Product Development Update: Intercell starts Phase II clinical trial for Pseudomonas aeruginosa vaccine and FDA approval of IXIAROVienna (Austria), December 29, 2008 - Intercell AG (VSE: "ICLL") today announced that the Phase II clinical trial with the company's vaccine candidate to prevent infections with the bacterium...
King Pharmaceuticals Initiates Phase II Clinical Trial Evaluating T-62 as a Treatment for Neuropathic PainBRISTOL, TENNESSEE, December 26, 2008 - King Pharmaceuticals, Inc. (NYSE: KG) today announced that it has initiated the Phase II clinical trial program evaluating the efficacy and safety of T-62, an...
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of EyelashesIRVINE, Calif., Dec 26, 2008 --Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a novel...
U.S. Federal Trade Commission Provisionally Accepts Consent Decree and Terminates Waiting Period for King Pharmaceuticals' Acquisition of AlpharmaBRISTOL, TENNESSEE and BRIDGEWATER, NEW JERSEY - December 26, 2008 - King Pharmaceuticals, Inc. (NYSE: KG) and Alpharma Inc. (NYSE: ALO) today announced that the U.S. Federal Trade Commission has...
Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of EyelashesIRVINE, Calif., Dec 26, 2008--Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a novel...
Notice of Execution of Acquisition of the Company's Own SharesOsaka, Japan, December 25, 2008 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of...
WILLIAM RANSOM & SON PLC AUDITED PRELIMINARY RESULTS FOR THE YEAR ENDED 31 MARCH 2008December 24, 2008-William Ransom & Son plc ('Ransom'), one of the UK's leading natural healthcare companies, is pleased to announce today its preliminary results for the year ended 31 March 2008. The...
|
| |
|
|
